This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Calcium Pyrophosphate Deposition Disease
Information about Calcium Pyrophosphate Deposition Disease: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Calcium Pyrophosphate Deposition Disease
Most recent studies have shown that Calcium Pyrophosphate Deposition Disease shares some biological mechanisms with abnormal-degeneration, ankylosing-spondylitis, arthritis, arthritis-infectious, arthropathy, calcinosis, calcium-pyrophosphate-arthropathy, degenerative-polyarthritis, gout, hemochromatosis, inflammation, neoplasms, pain, pyrophosphate-arthritis, rheumatism, rheumatoid-arthritis, synovitis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Calcium Pyrophosphate Deposition Disease, and have been seen in publications frequently: Acute Inflammatory Response, Aging, Anion Transport, Cell Activation, Cell Death, Cell Division, Chondrocyte Differentiation, Chondrocyte Hypertrophy, Diuresis, Excretion, Glomerular Filtration, Inflammatory Response, Localization, Ossification, Osteoclast Differentiation, Pathogenesis, Phagocytosis, Secretion, Translation, Transport
Quite a number of genes have been found to play important roles in Calcium Pyrophosphate Deposition Disease, such as ALPL, ANK1, ANKH, BCKDHA, C3, CAPG, CD46, CRP, ENPP1, ENPP3, HHIP, PKD1, PPA1, PTH, REG3A, RPL29, SLC12A3, ST13, TF, TPD52. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.